SCHEMBL7934041

SCHEMBL7934041

O=C(O)CCCCCC(=O)Nc1nc(CO)cs1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.60
PDE5A O76074 3/20 0.57
PDE1A P54750 1/20 0.55
PDE1B Q01064 1/20 0.55
PDE1C Q14123 1/20 0.55
LMNA P02545 1/20 0.53
MAPK1 P28482 1/20 0.53
HDAC1 Q13547 8/20 0.51
HDAC9 Q9UKV0 6/20 0.51
HDAC6 Q9UBN7 6/20 0.51
HDAC2 Q92769 6/20 0.51
HDAC3 O15379 4/20 0.51
HDAC4 P56524 4/20 0.51
HDAC7 Q8WUI4 4/20 0.51
HDAC10 Q969S8 4/20 0.51
HDAC11 Q96DB2 4/20 0.51
HDAC8 Q9BY41 4/20 0.51
HDAC5 Q9UQL6 4/20 0.51
GAA P10253 1/20 0.46
CA12 O43570 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20935220 0.84 PDE5A (0.66) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL7924468 0.81 POLB (0.58) POLBPDE5ALMNAMAPK1HDAC1
SCHEMBL1000799 0.80 PDE5A (0.79) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL7933437 0.78 POLB (0.50) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL465934 0.78 SMN1; SMN2 (0.51) POLBPDE5ALMNAMAPK1GAA
SCHEMBL7933417 0.78 LMNA (0.54) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL93110 0.77 PDE5A (0.76) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL20935426 0.77 GAA (0.49) POLBPDE5APDE1APDE1BPDE1C
SCHEMBL3235298 0.76 HDAC1 (0.54) PDE5APDE1APDE1BPDE1CLMNA
SCHEMBL3233655 0.76 HDAC1 (0.73) LMNAMAPK1HDAC1HDAC9HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed